Lipanthyl

Lipanthyl Brand names, Lipanthyl Analogs

Lipanthyl Brand Names Mixture

No information avaliable

Lipanthyl Chemical_Formula

C₂₀H₂₁ClO₄

Lipanthyl RX_link

http://www.rxlist.com/cgi/generic3/fenofibrate.htm

Lipanthyl fda sheet

Lipanthyl FDA

Lipanthyl msds (material safety sheet)

Lipanthyl MSDS

Lipanthyl Synthesis Reference

No information avaliable

Lipanthyl Molecular Weight

360.831 g/mol

Lipanthyl Melting Point

80.5 °C

Lipanthyl H₂O Solubility

0.25mg/ml at 25 °C

Lipanthyl State

Solid

Lipanthyl LogP

5.575

Lipanthyl Dosage Forms

Capsule; Tablet

Lipanthyl Indication

For use as adjunctive therapy to diet to reduce elevated LDL-C, Total-C,Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb)

Lipanthyl Pharmacology

Fenofibrate is a lipid regulating agent indicated as adjunctive therapy to diet to reduce elevated LDL-C, Total-C,Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb). Fenofibrate is also indicated as adjunctive therapy to diet for treatment of adult patients with hypertriglyceridemia (Fredrickson Types IV and V hyperlipidemia). Fenofibric acid, the active metabolite of Fenofibrate, produces reductions in total cholesterol, LDL cholesterol, apolipoprotein B, total triglycerides and triglyceride rich lipoprotein (VLDL) in treated patients. In addition, treatment with fenofibrate results in increases in high density lipoprotein (HDL) and apoproteins apoAI and apoAII.

Lipanthyl Absorption

Fenofibrate is well absorbed from the gastrointestinal tract. After absorption, fenofibrate is mainly excreted in the urine in the form of metabolites, primarily fenofibric acid and fenofibric acid glucuronide

Lipanthyl side effects and Toxicity

LD₅₀=1600 mg/kg (Oral, in mice); Investigated as a teratogen and reproductive hazard.

Lipanthyl Patient Information